Combined chemo-endocrine therapy as a potential new option for HR+/HER2− advanced breast cancer: a prospective study of fulvestrant plus oral vinorelbine

OBJECTIVE: Endocrine therapy with fulvestrant has shown synergistic antitumor effects with some chemotherapy drugs in vitro. This study evaluated the efficacy and safety of fulvestrant with vinorelbine in patients with hormone receptor positive (HR+)/human epidermal growth factor receptor-2-negative...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xue, Yue, Jian, Kang, Yikun, Dai, Zhong, Ju, Jie, Wang, Jiayu, Zhang, Pin, Ma, Fei, Xu, Binghe, Yuan, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157809/
https://www.ncbi.nlm.nih.gov/pubmed/37144559
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157809/
https://www.ncbi.nlm.nih.gov/pubmed/37144559
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0702

Ejemplares similares